Curis
CRIS
#10363
Rank
A$25.39 M
Marketcap
A$0.65
Share price
-2.77%
Change (1 day)
-82.71%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -A$50.91 Million

According to Curis's latest financial reports the company's current earnings are A$11.65 Million. In 2024 the company made an earning of -A$60.58 Million, an increase over its 2023 earnings that were of -A$64.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$50.91 Million-15.96%
2024 -A$60.58 Million-5.77%
2023 -A$64.29 Million-13.1%
2022 -A$73.98 Million27.52%
2021 -A$58.02 Million65.09%
2020 -A$35.15 Million-9.1%
2019 -A$38.66 Million-4.73%
2018 -A$40.58 Million-41.95%
2017 -A$69.9 Million-14.37%
2016 -A$81.63 Million3.55%
2015 -A$78.82 Million271.52%
2014 -A$21.22 Million76.64%
2013 -A$12.02 Million
2011 -A$10.21 Million27.76%
2010 -A$7.99 Million-43.87%
2009 -A$14.23 Million-23.44%
2008 -A$18.59 Million56.66%
2007 -A$11.87 Million-16.71%
2006 -A$14.24 Million-36.92%
2005 -A$22.58 Million156.25%
2004 -A$8.81 Million-37.24%
2003 -A$14.04 Million-93.34%
2002 -A$0.22 Billion86.79%
2001 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.99 B-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.59 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$87.64 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.42 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.41 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$35.07 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA